We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$280M
AUM Growth
-$7.34M
Cap. Flow
-$22.2M
Cap. Flow %
-7.92%
Top 10 Hldgs %
45.64%
Holding
951
New
8
Increased
46
Reduced
212
Closed
452

Top Buys

Rank Stock Value
1
DELL icon
Dell
DELL
+$3.14M
2
CB icon
Chubb
CB
+$208K
3
PFFD icon
Global X US Preferred ETF
PFFD
+$151K
4
TEL icon
TE Connectivity
TEL
+$138K
5
ANET icon
Arista Networks
ANET
+$80.1K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.52M
2
XOM icon
ExxonMobil
XOM
+$1.48M
3
CVX icon
Chevron
CVX
+$1.23M
4
LLY icon
Eli Lilly
LLY
+$866K
5
JPM icon
JPMorgan Chase
JPM
+$783K

Sector Composition

Rank Sector Weight
1 Technology 48.17%
2 Healthcare 8.71%
3 Consumer Staples 8.37%
4 Industrials 6.34%
5 Financials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRX icon
476
Xerox
XRX
$337M
$266 ﹤0.01%
25
– –
SHOP icon
477
Shopify
SHOP
$148B
$240 ﹤0.01%
3
-216
-99% -$14.9K
RBLX icon
478
Roblox
RBLX
$34B
$221 ﹤0.01%
5
– –
PCG icon
479
PG&E
PCG
$47.8B
$218 ﹤0.01%
11
– –
GAIA icon
480
Gaia
GAIA
$47.3M
$195 ﹤0.01%
40
– –
NATL icon
481
NCR Atleos
NATL
$3.52B
$171 ﹤0.01%
6
– –
VYX icon
482
NCR Voyix
VYX
$1.06B
$163 ﹤0.01%
12
– –
EGRX
483
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$149 ﹤0.01%
40
– –
RIOT icon
484
Riot Platforms
RIOT
$8.52B
$148 ﹤0.01%
20
– –
ARKG icon
485
ARK Genomic Revolution ETF
ARKG
$1.51B
$128 ﹤0.01%
5
– –
VTRS icon
486
Viatris
VTRS
$20.1B
$125 ﹤0.01%
11
-880
-99% -$10.2K
CNDT icon
487
Conduent
CNDT
$230M
$81 ﹤0.01%
20
– –
XYZ
488
Block Inc
XYZ
$45.9B
$67 ﹤0.01%
1
-675
-100% -$43.6K
OGN icon
489
Organon & Co
OGN
$3.55B
$61 ﹤0.01%
3
-10
-77% -$207
LUV icon
490
Southwest Airlines
LUV
$22.1B
$59 ﹤0.01%
2
– –
F icon
491
Ford
F
$57.3B
$53 ﹤0.01%
+5
New +$57
LUMN icon
492
Lumen
LUMN
$6.53B
$50 ﹤0.01%
7
-1,500
-100% -$6.4K
CHRN
493
ChronoScale Holdings
CHRN
$3.12B
$36 ﹤0.01%
2
– –
AGEN
494
Agenus
AGEN
$249M
$27 ﹤0.01%
5
– –
TVRD
495
Tvardi Therapeutics
TVRD
$23.5M
$25 ﹤0.01%
2
– –
RLMD icon
496
Relmada Therapeutics
RLMD
$544M
$19 ﹤0.01%
6
– –
ABNB icon
497
Airbnb
ABNB
$83.7B
– –
-147
Closed -$22.3K
ACGL icon
498
Arch Capital
ACGL
$36.1B
– –
-66
Closed -$6.66K
ACHC icon
499
Acadia Healthcare
ACHC
$3.17B
– –
-80
Closed -$5.4K
ADBE icon
500
Adobe
ADBE
$89.5B
– –
-444
Closed -$247K
18 19
20
21 22

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Front Row Advisors held 951 positions worth $280M, down 2.6% from $288M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Front Row Advisors withdrew a net $22.2M in Q3 2024, closing 452 positions and reducing 212 holdings. Its most notable exit was Vanguard Information Technology ETF, an estimated $578K position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Front Row Advisors opened a new position in Global X US Preferred ETF worth $156K.

  • Front Row Advisors's largest Q3 2024 buy was Global X US Preferred ETF: 7,500 shares worth $156K.
  • Front Row Advisors added most to Dell in Q3 2024, an estimated $3.14M increase.
  • Front Row Advisors's biggest Q3 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $1.52M.
  • Front Row Advisors fully exited Vanguard Information Technology ETF in Q3 2024, selling an estimated $578K.
  • Front Row Advisors's ten largest holdings make up 46% of its $280M portfolio in Q3 2024.
  • Front Row Advisors opened 8 new positions and closed 452 in Q3 2024.
  • Front Row Advisors's portfolio value fell 2.6% quarter-over-quarter to $280M.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.